profit slide india's dr reddy profit indian drugmaker dr reddy's fell 93 research cost rose sale flagged firm said profit 40m rupee 915 000 486 000 three month december sale fell 7bn rupee dr reddy's built reputation producing generic version big name pharmaceutical product competition intensified firm company short new product launch recent annoucement december 2000 exclusive marketing right generic version famous anti depressant prozac maker eli lilly also lost key court case march 2004 banning selling version pfizer's popular hypertension drug norvasc u research development new drug continuing apace spending rising 37 705m rupee key cause decrease profit alongside fall sale patent number well known product due run near future representing opportunity dr reddy whose share listed new york indian generic manufacturer sale dr reddy's generic business fell 966m rupee another staple firm's business sale ingredient drug also performed poorly sale 25 previous year 4bn rupee face strong competition home u europe dr reddy's indian competitor gathering strength although face heavy competitive pressure